Physician profile
Shaili Gal
NPI 1033524012
$1,947.12
in general payments reported to CMS, 2019-2025
7 companies · $33.39 in 2025
The $33.39 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2021: $250 · 2022: $450 · 2023: $164 · 2024: $765 · 2025: $33.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $550 · Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $550.00 |
| Food and Beverage | $412.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,285.68 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $214.26 | 2019 | |
| Davol INC. | $198.36 | 2022 | |
| Sientra, INC. | $97.81 | 2021-2022 | |
| Abbvie INC. | $68.60 | 2024 | |
| Merz North America, INC. | $51.55 | 2019 | |
| Bard Peripheral Vascular, INC. | $30.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaili Gal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.